08/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/2023

Aug 25, 2023, 21:14 | Insight
Jurjen Versluis: Allogeneic HCT should be considered as a curative treatment for all patients with high-risk MDS.
Jurjen Versluis, Internist hematologist and Researcher at Erasmus MC, shared the following insights on Twitter:…
Aug 25, 2023, 20:52 | Opinion
Eric K. Singhi: Can we please ensure peer to peer insurance conversations are with… a peer?
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, made the following post…
Aug 25, 2023, 18:30 | Career
Emrullah Yilmaz: I’m happy to share that I’m starting a new position as Director of Precision Oncology at Cleveland Clinic!
Quoting Emrullah Yilmaz, the Director of Precision Oncology at Cleveland Clinic, on LinkedIn: "I’m happy…
Aug 25, 2023, 18:28 | Blog
Submit an Abstract for the 2023 Young Investigator Symposium by Wednesday, 9/6! - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared on their Twitter page: ''Submit an Abstract for the 2023…
Aug 25, 2023, 18:26 | Insight
Sara Tolaney: TROPICS-02 Overall Survival data now published in The Lancet!
Quoting Sara Tolaney, Chief of Division of Breast Oncology at Dana Farber Cancer Institute, on…
Aug 25, 2023, 18:25 | Insight
Arndt Vogel: Immune Checkpoint Inhibitors for Child-Pugh B HCC: comprehensive summary of 22 studies with 699 patients.
Quoting Arndt Vogel on X/Twitter: "Hot off the press: Immune Checkpoint Inhibitors for CP B…
Aug 25, 2023, 18:25 | Opinion
Sachin H. Jain: Being comfortable saying: “I don’t know” is paradoxically one of the most important ways we build trust with one another.
Quoting Sachin H. Jain, the President and CEO of SCAN Group & Health Plan, on…
Aug 25, 2023, 18:25 | Career
David Steensma: I’m excited to have started this new role as Chief Medical Officer of AjaxTherapeutics.
Quoting David Steensma, former Global Head of Hematology at Novartis Institutes for BioMedical Research (NIBR),…
Aug 25, 2023, 18:24 | Blog
Selwyn Vickers: An innovative, first-of-its-kind PhD program was just announced at Memorial Sloan Kettering Cancer Center’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences.
Aug 25, 2023, 18:23 | Career
Crystal S. Denlinger is named new CEO of NCCN. - National Comprehensive Cancer Network
According to National Comprehensive Cancer Network (NCCN) on LinkedIn: "Crystal S. Denlinger, MD, FACP, is…
All: 539 Posts: 101 - 110